Novartis AG ADR (NVS)vsQMMM Holdings Limited Ordinary Shares (QMMM)
NVS
Novartis AG ADR
$150.75
+1.44%
HEALTHCARE · Cap: $286.27B
QMMM
QMMM Holdings Limited Ordinary Shares
$119.40
0.00%
COMMUNICATION SERVICES · Cap: $6.83B
Smart Verdict
WallStSmart Research — data-driven comparison
Novartis AG ADR generates 3020419% more annual revenue ($56.67B vs $1.88M). NVS leads profitability with a 24.7% profit margin vs -1.5%. NVS earns a higher WallStSmart Score of 51/100 (C-).
NVS
Buy51
out of 100
Grade: C-
QMMM
Avoid14
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-243.7%
Fair Value
$48.62
Current Price
$150.75
$102.13 premium
Intrinsic value data unavailable for QMMM.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Every $100 of equity generates 31 in profit
Keeps 25 of every $100 in revenue as profit
Strong operational efficiency at 27.8%
Generating 1.6B in free cash flow
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Areas to Watch
2.2% revenue growth
Grey zone — moderate risk
Expensive relative to growth rate
Earnings declined 11.6%
0.0% earnings growth
Weak financial health signals
Trading at 519.1x book value
ROE of -2.0% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : NVS
The strongest argument for NVS centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 24.7% and operating margin at 27.8%.
Bull Case : QMMM
The strongest argument for QMMM centers on Debt/Equity, Altman Z-Score.
Bear Case : NVS
The primary concerns for NVS are Revenue Growth, Altman Z-Score, PEG Ratio.
Bear Case : QMMM
The primary concerns for QMMM are EPS Growth, Piotroski F-Score, Price/Book.
Key Dynamics to Monitor
NVS profiles as a value stock while QMMM is a turnaround play — different risk/reward profiles.
NVS is growing revenue faster at 2.2% — sustainability is the question.
NVS generates stronger free cash flow (1.6B), providing more financial flexibility.
Monitor DRUG MANUFACTURERS - GENERAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
NVS scores higher overall (51/100 vs 14/100), backed by strong 24.7% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Novartis AG ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Visit Website →QMMM Holdings Limited Ordinary Shares
COMMUNICATION SERVICES · ADVERTISING AGENCIES · USA
QMMM Holdings Limited, provides digital media advertising and marketing production services primarily in Hong Kong.
Visit Website →Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?